TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. NARCOLEPSY MARKET, BY TYPE OF NARCOLEPSY (USD BILLION)
6.1. Type 1 Narcolepsy
6.2. Type 2 Narcolepsy
6.3. Secondary Narcolepsy
7. NARCOLEPSY MARKET, BY DIAGNOSIS METHOD (USD BILLION)
7.1. Polysomnography
7.2. Multiple Sleep Latency Test
7.3. Clinical Evaluation
8. NARCOLEPSY MARKET, BY TREATMENT TYPE (USD BILLION)
8.1. Stimulants
8.2. Sodium Oxybate
8.3. Wakefulness-Promoting Agents
8.4. Antidepressants
9. NARCOLEPSY MARKET, BY END USER (USD BILLION)
9.1. Hospitals
9.2. Clinics
9.3. Home Care Settings
10. NARCOLEPSY MARKET, BY REGIONAL (USD BILLION)
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. UK
10.2.3. France
10.2.4. Russia
10.2.5. Italy
10.2.6. Spain
10.2.7. Rest of Europe
10.3. APAC
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Malaysia
10.3.6. Thailand
10.3.7. Indonesia
10.3.8. Rest of APAC
10.4. South America
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Argentina
10.4.4. Rest of South America
10.5. MEA
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of MEA
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market share Analysis
11.4. Major Growth Strategy in the Narcolepsy Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Narcolepsy Market
11.7. Key developments and growth strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales and Operating Income
11.8.2. Major Players R&D Expenditure. 2023
12. COMPANY PROFILES
12.1. BristolMyers Squibb
12.1.1. Financial Overview
12.1.2. Products Offered
12.1.3. Key Developments
12.1.4. SWOT Analysis
12.1.5. Key Strategies
12.2. Sleep Therapeutics
12.2.1. Financial Overview
12.2.2. Products Offered
12.2.3. Key Developments
12.2.4. SWOT Analysis
12.2.5. Key Strategies
12.3. Arena Pharmaceuticals
12.3.1. Financial Overview
12.3.2. Products Offered
12.3.3. Key Developments
12.3.4. SWOT Analysis
12.3.5. Key Strategies
12.4. Sanofi
12.4.1. Financial Overview
12.4.2. Products Offered
12.4.3. Key Developments
12.4.4. SWOT Analysis
12.4.5. Key Strategies
12.5. Modus Therapeutics
12.5.1. Financial Overview
12.5.2. Products Offered
12.5.3. Key Developments
12.5.4. SWOT Analysis
12.5.5. Key Strategies
12.6. AstraZeneca
12.6.1. Financial Overview
12.6.2. Products Offered
12.6.3. Key Developments
12.6.4. SWOT Analysis
12.6.5. Key Strategies
12.7. Teva Pharmaceutical Industries
12.7.1. Financial Overview
12.7.2. Products Offered
12.7.3. Key Developments
12.7.4. SWOT Analysis
12.7.5. Key Strategies
12.8. Jazz Pharmaceuticals
12.8.1. Financial Overview
12.8.2. Products Offered
12.8.3. Key Developments
12.8.4. SWOT Analysis
12.8.5. Key Strategies
12.9. Eisai
12.9.1. Financial Overview
12.9.2. Products Offered
12.9.3. Key Developments
12.9.4. SWOT Analysis
12.9.5. Key Strategies
12.10. Otsuka Pharmaceutical
12.10.1. Financial Overview
12.10.2. Products Offered
12.10.3. Key Developments
12.10.4. SWOT Analysis
12.10.5. Key Strategies
12.11. Avadel Pharmaceuticals
12.11.1. Financial Overview
12.11.2. Products Offered
12.11.3. Key Developments
12.11.4. SWOT Analysis
12.11.5. Key Strategies
12.12. Hikma Pharmaceuticals
12.12.1. Financial Overview
12.12.2. Products Offered
12.12.3. Key Developments
12.12.4. SWOT Analysis
12.12.5. Key Strategies
12.13. NorthStar Healthcare
12.13.1. Financial Overview
12.13.2. Products Offered
12.13.3. Key Developments
12.13.4. SWOT Analysis
12.13.5. Key Strategies
12.14. Vanda Pharmaceuticals
12.14.1. Financial Overview
12.14.2. Products Offered
12.14.3. Key Developments
12.14.4. SWOT Analysis
12.14.5. Key Strategies
12.15. Novartis
12.15.1. Financial Overview
12.15.2. Products Offered
12.15.3. Key Developments
12.15.4. SWOT Analysis
12.15.5. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 3. NORTH AMERICA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 4. NORTH AMERICA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 5. NORTH AMERICA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 6. NORTH AMERICA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 7. US NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 8. US NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 9. US NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 10. US NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 11. US NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 12. CANADA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 13. CANADA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 14. CANADA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 15. CANADA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 16. CANADA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 17. EUROPE NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 18. EUROPE NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 19. EUROPE NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 20. EUROPE NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 21. EUROPE NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 22. GERMANY NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 23. GERMANY NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 24. GERMANY NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 25. GERMANY NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 26. GERMANY NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 27. UK NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 28. UK NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 29. UK NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 30. UK NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 31. UK NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 32. FRANCE NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 33. FRANCE NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 34. FRANCE NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 35. FRANCE NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 36. FRANCE NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 37. RUSSIA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 38. RUSSIA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 39. RUSSIA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 40. RUSSIA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 41. RUSSIA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 42. ITALY NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 43. ITALY NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 44. ITALY NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 45. ITALY NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 46. ITALY NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 47. SPAIN NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 48. SPAIN NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 49. SPAIN NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 50. SPAIN NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 51. SPAIN NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 52. REST OF EUROPE NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 53. REST OF EUROPE NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 54. REST OF EUROPE NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 55. REST OF EUROPE NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 56. REST OF EUROPE NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 57. APAC NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 58. APAC NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 59. APAC NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 60. APAC NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 61. APAC NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 62. CHINA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 63. CHINA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 64. CHINA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 65. CHINA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 66. CHINA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 67. INDIA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 68. INDIA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 69. INDIA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 70. INDIA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 71. INDIA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 72. JAPAN NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 73. JAPAN NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 74. JAPAN NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 75. JAPAN NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 76. JAPAN NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 77. SOUTH KOREA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 78. SOUTH KOREA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 79. SOUTH KOREA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 80. SOUTH KOREA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 81. SOUTH KOREA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 82. MALAYSIA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 83. MALAYSIA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 84. MALAYSIA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 85. MALAYSIA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 86. MALAYSIA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 87. THAILAND NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 88. THAILAND NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 89. THAILAND NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 90. THAILAND NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 91. THAILAND NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 92. INDONESIA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 93. INDONESIA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 94. INDONESIA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 95. INDONESIA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 96. INDONESIA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 97. REST OF APAC NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 98. REST OF APAC NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 99. REST OF APAC NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 100. REST OF APAC NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 101. REST OF APAC NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 102. SOUTH AMERICA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 103. SOUTH AMERICA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 104. SOUTH AMERICA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 105. SOUTH AMERICA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 106. SOUTH AMERICA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 107. BRAZIL NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 108. BRAZIL NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 109. BRAZIL NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 110. BRAZIL NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 111. BRAZIL NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 112. MEXICO NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 113. MEXICO NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 114. MEXICO NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 115. MEXICO NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 116. MEXICO NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 117. ARGENTINA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 118. ARGENTINA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 119. ARGENTINA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 120. ARGENTINA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 121. ARGENTINA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 122. REST OF SOUTH AMERICA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 123. REST OF SOUTH AMERICA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 124. REST OF SOUTH AMERICA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 125. REST OF SOUTH AMERICA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 126. REST OF SOUTH AMERICA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 127. MEA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 128. MEA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 129. MEA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 130. MEA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 131. MEA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 132. GCC COUNTRIES NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 133. GCC COUNTRIES NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 134. GCC COUNTRIES NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 135. GCC COUNTRIES NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 136. GCC COUNTRIES NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 137. SOUTH AFRICA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 138. SOUTH AFRICA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 139. SOUTH AFRICA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 140. SOUTH AFRICA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 141. SOUTH AFRICA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 142. REST OF MEA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF NARCOLEPSY, 2019-2032 (USD BILLIONS)
TABLE 143. REST OF MEA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY DIAGNOSIS METHOD, 2019-2032 (USD BILLIONS)
TABLE 144. REST OF MEA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 145. REST OF MEA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 146. REST OF MEA NARCOLEPSY MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 148. ACQUISITION/PARTNERSHIP
LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA NARCOLEPSY MARKET ANALYSIS
FIGURE 3. US NARCOLEPSY MARKET ANALYSIS BY TYPE OF NARCOLEPSY
FIGURE 4. US NARCOLEPSY MARKET ANALYSIS BY DIAGNOSIS METHOD
FIGURE 5. US NARCOLEPSY MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 6. US NARCOLEPSY MARKET ANALYSIS BY END USER
FIGURE 7. US NARCOLEPSY MARKET ANALYSIS BY REGIONAL
FIGURE 8. CANADA NARCOLEPSY MARKET ANALYSIS BY TYPE OF NARCOLEPSY
FIGURE 9. CANADA NARCOLEPSY MARKET ANALYSIS BY DIAGNOSIS METHOD
FIGURE 10. CANADA NARCOLEPSY MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 11. CANADA NARCOLEPSY MARKET ANALYSIS BY END USER
FIGURE 12. CANADA NARCOLEPSY MARKET ANALYSIS BY REGIONAL
FIGURE 13. EUROPE NARCOLEPSY MARKET ANALYSIS
FIGURE 14. GERMANY NARCOLEPSY MARKET ANALYSIS BY TYPE OF NARCOLEPSY
FIGURE 15. GERMANY NARCOLEPSY MARKET ANALYSIS BY DIAGNOSIS METHOD
FIGURE 16. GERMANY NARCOLEPSY MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 17. GERMANY NARCOLEPSY MARKET ANALYSIS BY END USER
FIGURE 18. GERMANY NARCOLEPSY MARKET ANALYSIS BY REGIONAL
FIGURE 19. UK NARCOLEPSY MARKET ANALYSIS BY TYPE OF NARCOLEPSY
FIGURE 20. UK NARCOLEPSY MARKET ANALYSIS BY DIAGNOSIS METHOD
FIGURE 21. UK NARCOLEPSY MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 22. UK NARCOLEPSY MARKET ANALYSIS BY END USER
FIGURE 23. UK NARCOLEPSY MARKET ANALYSIS BY REGIONAL
FIGURE 24. FRANCE NARCOLEPSY MARKET ANALYSIS BY TYPE OF NARCOLEPSY
FIGURE 25. FRANCE NARCOLEPSY MARKET ANALYSIS BY DIAGNOSIS METHOD
FIGURE 26. FRANCE NARCOLEPSY MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 27. FRANCE NARCOLEPSY MARKET ANALYSIS BY END USER
FIGURE 28. FRANCE NARCOLEPSY MARKET ANALYSIS BY REGIONAL
FIGURE 29. RUSSIA NARCOLEPSY MARKET ANALYSIS BY TYPE OF NARCOLEPSY
FIGURE 30. RUSSIA NARCOLEPSY MARKET ANALYSIS BY DIAGNOSIS METHOD
FIGURE 31. RUSSIA NARCOLEPSY MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 32. RUSSIA NARCOLEPSY MARKET ANALYSIS BY END USER
FIGURE 33. RUSSIA NARCOLEPSY MARKET ANALYSIS BY REGIONAL
FIGURE 34. ITALY NARCOLEPSY MARKET ANALYSIS BY TYPE OF NARCOLEPSY
FIGURE 35. ITALY NARCOLEPSY MARKET ANALYSIS BY DIAGNOSIS METHOD
FIGURE 36. ITALY NARCOLEPSY MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 37. ITALY NARCOLEPSY MARKET ANALYSIS BY END USER
FIGURE 38. ITALY NARCOLEPSY MARKET ANALYSIS BY REGIONAL
FIGURE 39. SPAIN NARCOLEPSY MARKET ANALYSIS BY TYPE OF NARCOLEPSY
FIGURE 40. SPAIN NARCOLEPSY MARKET ANALYSIS BY DIAGNOSIS METHOD
FIGURE 41. SPAIN NARCOLEPSY MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 42. SPAIN NARCOLEPSY MARKET ANALYSIS BY END USER
FIGURE 43. SPAIN NARCOLEPSY MARKET ANALYSIS BY REGIONAL
FIGURE 44. REST OF EUROPE NARCOLEPSY MARKET ANALYSIS BY TYPE OF NARCOLEPSY
FIGURE 45. REST OF EUROPE NARCOLEPSY MARKET ANALYSIS BY DIAGNOSIS METHOD
FIGURE 46. REST OF EUROPE NARCOLEPSY MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 47. REST OF EUROPE NARCOLEPSY MARKET ANALYSIS BY END USER
FIGURE 48. REST OF EUROPE NARCOLEPSY MARKET ANALYSIS BY REGIONAL
FIGURE 49. APAC NARCOLEPSY MARKET ANALYSIS
FIGURE 50. CHINA NARCOLEPSY MARKET ANALYSIS BY TYPE OF NARCOLEPSY
FIGURE 51. CHINA NARCOLEPSY MARKET ANALYSIS BY DIAGNOSIS METHOD
FIGURE 52. CHINA NARCOLEPSY MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 53. CHINA NARCOLEPSY MARKET ANALYSIS BY END USER
FIGURE 54. CHINA NARCOLEPSY MARKET ANALYSIS BY REGIONAL
FIGURE 55. INDIA NARCOLEPSY MARKET ANALYSIS BY TYPE OF NARCOLEPSY
FIGURE 56. INDIA NARCOLEPSY MARKET ANALYSIS BY DIAGNOSIS METHOD
FIGURE 57. INDIA NARCOLEPSY MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 58. INDIA NARCOLEPSY MARKET ANALYSIS BY END USER
FIGURE 59. INDIA NARCOLEPSY MARKET ANALYSIS BY REGIONAL
FIGURE 60. JAPAN NARCOLEPSY MARKET ANALYSIS BY TYPE OF NARCOLEPSY
FIGURE 61. JAPAN NARCOLEPSY MARKET ANALYSIS BY DIAGNOSIS METHOD
FIGURE 62. JAPAN NARCOLEPSY MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 63. JAPAN NARCOLEPSY MARKET ANALYSIS BY END USER
FIGURE 64. JAPAN NARCOLEPSY MARKET ANALYSIS BY REGIONAL
FIGURE 65. SOUTH KOREA NARCOLEPSY MARKET ANALYSIS BY TYPE OF NARCOLEPSY
FIGURE 66. SOUTH KOREA NARCOLEPSY MARKET ANALYSIS BY DIAGNOSIS METHOD
FIGURE 67. SOUTH KOREA NARCOLEPSY MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 68. SOUTH KOREA NARCOLEPSY MARKET ANALYSIS BY END USER
FIGURE 69. SOUTH KOREA NARCOLEPSY MARKET ANALYSIS BY REGIONAL
FIGURE 70. MALAYSIA NARCOLEPSY MARKET ANALYSIS BY TYPE OF NARCOLEPSY
FIGURE 71. MALAYSIA NARCOLEPSY MARKET ANALYSIS BY DIAGNOSIS METHOD
FIGURE 72. MALAYSIA NARCOLEPSY MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 73. MALAYSIA NARCOLEPSY MARKET ANALYSIS BY END USER
FIGURE 74. MALAYSIA NARCOLEPSY MARKET ANALYSIS BY REGIONAL
FIGURE 75. THAILAND NARCOLEPSY MARKET ANALYSIS BY TYPE OF NARCOLEPSY
FIGURE 76. THAILAND NARCOLEPSY MARKET ANALYSIS BY DIAGNOSIS METHOD
FIGURE 77. THAILAND NARCOLEPSY MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 78. THAILAND NARCOLEPSY MARKET ANALYSIS BY END USER
FIGURE 79. THAILAND NARCOLEPSY MARKET ANALYSIS BY REGIONAL
FIGURE 80. INDONESIA NARCOLEPSY MARKET ANALYSIS BY TYPE OF NARCOLEPSY
FIGURE 81. INDONESIA NARCOLEPSY MARKET ANALYSIS BY DIAGNOSIS METHOD
FIGURE 82. INDONESIA NARCOLEPSY MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 83. INDONESIA NARCOLEPSY MARKET ANALYSIS BY END USER
FIGURE 84. INDONESIA NARCOLEPSY MARKET ANALYSIS BY REGIONAL
FIGURE 85. REST OF APAC NARCOLEPSY MARKET ANALYSIS BY TYPE OF NARCOLEPSY
FIGURE 86. REST OF APAC NARCOLEPSY MARKET ANALYSIS BY DIAGNOSIS METHOD
FIGURE 87. REST OF APAC NARCOLEPSY MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 88. REST OF APAC NARCOLEPSY MARKET ANALYSIS BY END USER
FIGURE 89. REST OF APAC NARCOLEPSY MARKET ANALYSIS BY REGIONAL
FIGURE 90. SOUTH AMERICA NARCOLEPSY MARKET ANALYSIS
FIGURE 91. BRAZIL NARCOLEPSY MARKET ANALYSIS BY TYPE OF NARCOLEPSY
FIGURE 92. BRAZIL NARCOLEPSY MARKET ANALYSIS BY DIAGNOSIS METHOD
FIGURE 93. BRAZIL NARCOLEPSY MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 94. BRAZIL NARCOLEPSY MARKET ANALYSIS BY END USER
FIGURE 95. BRAZIL NARCOLEPSY MARKET ANALYSIS BY REGIONAL
FIGURE 96. MEXICO NARCOLEPSY MARKET ANALYSIS BY TYPE OF NARCOLEPSY
FIGURE 97. MEXICO NARCOLEPSY MARKET ANALYSIS BY DIAGNOSIS METHOD
FIGURE 98. MEXICO NARCOLEPSY MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 99. MEXICO NARCOLEPSY MARKET ANALYSIS BY END USER
FIGURE 100. MEXICO NARCOLEPSY MARKET ANALYSIS BY REGIONAL
FIGURE 101. ARGENTINA NARCOLEPSY MARKET ANALYSIS BY TYPE OF NARCOLEPSY
FIGURE 102. ARGENTINA NARCOLEPSY MARKET ANALYSIS BY DIAGNOSIS METHOD
FIGURE 103. ARGENTINA NARCOLEPSY MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 104. ARGENTINA NARCOLEPSY MARKET ANALYSIS BY END USER
FIGURE 105. ARGENTINA NARCOLEPSY MARKET ANALYSIS BY REGIONAL
FIGURE 106. REST OF SOUTH AMERICA NARCOLEPSY MARKET ANALYSIS BY TYPE OF NARCOLEPSY
FIGURE 107. REST OF SOUTH AMERICA NARCOLEPSY MARKET ANALYSIS BY DIAGNOSIS METHOD
FIGURE 108. REST OF SOUTH AMERICA NARCOLEPSY MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 109. REST OF SOUTH AMERICA NARCOLEPSY MARKET ANALYSIS BY END USER
FIGURE 110. REST OF SOUTH AMERICA NARCOLEPSY MARKET ANALYSIS BY REGIONAL
FIGURE 111. MEA NARCOLEPSY MARKET ANALYSIS
FIGURE 112. GCC COUNTRIES NARCOLEPSY MARKET ANALYSIS BY TYPE OF NARCOLEPSY
FIGURE 113. GCC COUNTRIES NARCOLEPSY MARKET ANALYSIS BY DIAGNOSIS METHOD
FIGURE 114. GCC COUNTRIES NARCOLEPSY MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 115. GCC COUNTRIES NARCOLEPSY MARKET ANALYSIS BY END USER
FIGURE 116. GCC COUNTRIES NARCOLEPSY MARKET ANALYSIS BY REGIONAL
FIGURE 117. SOUTH AFRICA NARCOLEPSY MARKET ANALYSIS BY TYPE OF NARCOLEPSY
FIGURE 118. SOUTH AFRICA NARCOLEPSY MARKET ANALYSIS BY DIAGNOSIS METHOD
FIGURE 119. SOUTH AFRICA NARCOLEPSY MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 120. SOUTH AFRICA NARCOLEPSY MARKET ANALYSIS BY END USER
FIGURE 121. SOUTH AFRICA NARCOLEPSY MARKET ANALYSIS BY REGIONAL
FIGURE 122. REST OF MEA NARCOLEPSY MARKET ANALYSIS BY TYPE OF NARCOLEPSY
FIGURE 123. REST OF MEA NARCOLEPSY MARKET ANALYSIS BY DIAGNOSIS METHOD
FIGURE 124. REST OF MEA NARCOLEPSY MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 125. REST OF MEA NARCOLEPSY MARKET ANALYSIS BY END USER
FIGURE 126. REST OF MEA NARCOLEPSY MARKET ANALYSIS BY REGIONAL
FIGURE 127. KEY BUYING CRITERIA OF NARCOLEPSY MARKET
FIGURE 128. RESEARCH PROCESS OF MRFR
FIGURE 129. DRO ANALYSIS OF NARCOLEPSY MARKET
FIGURE 130. DRIVERS IMPACT ANALYSIS: NARCOLEPSY MARKET
FIGURE 131. RESTRAINTS IMPACT ANALYSIS: NARCOLEPSY MARKET
FIGURE 132. SUPPLY / VALUE CHAIN: NARCOLEPSY MARKET
FIGURE 133. NARCOLEPSY MARKET, BY TYPE OF NARCOLEPSY, 2024 (% SHARE)
FIGURE 134. NARCOLEPSY MARKET, BY TYPE OF NARCOLEPSY, 2019 TO 2032 (USD Billions)
FIGURE 135. NARCOLEPSY MARKET, BY DIAGNOSIS METHOD, 2024 (% SHARE)
FIGURE 136. NARCOLEPSY MARKET, BY DIAGNOSIS METHOD, 2019 TO 2032 (USD Billions)
FIGURE 137. NARCOLEPSY MARKET, BY TREATMENT TYPE, 2024 (% SHARE)
FIGURE 138. NARCOLEPSY MARKET, BY TREATMENT TYPE, 2019 TO 2032 (USD Billions)
FIGURE 139. NARCOLEPSY MARKET, BY END USER, 2024 (% SHARE)
FIGURE 140. NARCOLEPSY MARKET, BY END USER, 2019 TO 2032 (USD Billions)
FIGURE 141. NARCOLEPSY MARKET, BY REGIONAL, 2024 (% SHARE)
FIGURE 142. NARCOLEPSY MARKET, BY REGIONAL, 2019 TO 2032 (USD Billions)
FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS
